ANIXA BIOSCIENCES, INC. Other Noncash Income (Expense)
ANIXA BIOSCIENCES, INC. (ANIX) reported Other Noncash Income (Expense) of -$24.91 thousand for the 9-month period ending 2016-07-31, per its 10-Q filed 2016-08-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2016-08-19
- ANIXA BIOSCIENCES, INC. other noncash income (expense) for the quarter ending 2016-07-31 was -$11.03K.
- ANIXA BIOSCIENCES, INC. other noncash income (expense) for the quarter ending 2015-10-31 was -$3.83K.
- ANIXA BIOSCIENCES, INC. other noncash income (expense) for the quarter ending 2015-07-31 was -$3.83K.
- ANIXA BIOSCIENCES, INC. other noncash income (expense) for the quarter ending 2015-04-30 was -$8.90K.
- ANIXA BIOSCIENCES, INC. other noncash income (expense) for fiscal 2015 was -$23.20K.
- ANIXA BIOSCIENCES, INC. other noncash income (expense) for fiscal 2014 was -$38.23K.
- ANIXA BIOSCIENCES, INC. other noncash income (expense) for fiscal 2013 was -$9.75K, a 222.59% decline from fiscal 2012.
- ANIXA BIOSCIENCES, INC. other noncash income (expense) for fiscal 2012 was $7.96K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-07-31 | -$11.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-19 | -$24.91K 10-Q · filed 2016-08-19 | ||||||
| 2016-04-30 | -$13.88K 10-Q · filed 2016-05-20 | |||||||
| 2015-10-31 | -$3.83K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | -$7.66K derived: sum of 2 quarters · filed 2016-08-19 | -$16.56K derived: sum of 3 quarters · filed 2016-08-19 | -$23.20K 10-K · filed 2015-12-23 | ||||
| 2015-07-31 | -$3.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-19 | -$12.73K derived: sum of 2 quarters · filed 2016-08-19 | -$19.36K 10-Q · filed 2016-08-19 | -$58.14K derived: sum of 4 quarters · filed 2016-08-19 | ||||
| 2015-04-30 | -$8.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | -$15.53K 10-Q · filed 2016-05-20 | -$54.31K derived: sum of 3 quarters · filed 2016-05-20 | -$55.16K derived: sum of 4 quarters · filed 2016-05-20 | ||||
| 2015-01-31 | -$6.63K 10-Q · filed 2016-02-19 | -$7.66K 10-Q · filed 2015-03-09 | -$45.41K derived: sum of 2 quarters · filed 2016-02-19 | -$46.26K derived: sum of 3 quarters · filed 2016-02-19 | -$46.96K derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-10-31 | -$38.78K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | -$39.63K derived: sum of 2 quarters · filed 2015-12-23 | -$40.32K derived: sum of 3 quarters · filed 2015-12-23 | -$38.23K 10-K · filed 2015-12-23 | ||||
| 2014-07-31 | -$850.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | -$1.54K derived: sum of 2 quarters · filed 2015-08-18 | $553.00 10-Q · filed 2015-08-18 | $26.29K derived: sum of 4 quarters · filed 2015-08-18 | ||||
| 2014-04-30 | -$693.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-22 | $1.40K 10-Q · filed 2015-05-22 | $27.14K derived: sum of 3 quarters · filed 2015-05-22 | $27.46K derived: sum of 4 quarters · filed 2015-05-22 | ||||
| 2014-01-31 | $2.10K 10-Q · filed 2015-03-09 | $27.83K derived: sum of 2 quarters · filed 2015-03-09 | $28.15K derived: sum of 3 quarters · filed 2015-03-09 | $26.29K derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-10-31 | $25.74K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | $26.06K derived: sum of 2 quarters · filed 2015-01-29 | $24.19K derived: sum of 3 quarters · filed 2015-01-29 | -$9.75K 10-K · filed 2015-01-29 | $9.75K 10-K/A · filed 2014-01-17 | |||
| 2013-07-31 | $319.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | -$1.54K derived: sum of 2 quarters · filed 2014-09-15 | -$35.49K 10-Q · filed 2014-09-15 | -$9.00K 10-Q/A · filed 2013-09-20 | -$21.70K derived: sum of 4 quarters · filed 2014-09-15 | |||
| 2013-04-30 | -$1.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-16 | -$35.81K 10-Q · filed 2014-06-16 | $2.15K 10-Q/A · filed 2013-06-19 | -$22.02K derived: sum of 3 quarters · filed 2014-06-16 | -$31.29K derived: sum of 4 quarters · filed 2014-06-16 | |||
| 2013-01-31 | -$33.95K 10-Q · filed 2014-03-17 | -$20.15K derived: sum of 2 quarters · filed 2014-03-17 | -$29.42K derived: sum of 3 quarters · filed 2014-03-17 | -$25.71K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-10-31 | $13.79K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-01-17 | $4.52K derived: sum of 2 quarters · filed 2014-01-17 | $8.23K derived: sum of 3 quarters · filed 2014-01-17 | $7.96K 10-K/A · filed 2014-01-17 | $1.72K 10-K · filed 2013-01-29 | |||
| 2012-07-31 | -$9.27K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-09-20 | -$5.56K derived: sum of 2 quarters · filed 2013-09-20 | -$5.83K 10-Q/A · filed 2013-09-20 | $212.00 10-Q · filed 2012-09-14 | -$6.28K derived: sum of 4 quarters · filed 2013-09-20 | |||
| 2012-04-30 | $3.71K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-06-19 | $3.43K 10-Q/A · filed 2013-06-19 | $478.00 10-Q · filed 2012-06-14 | $2.99K derived: sum of 3 quarters · filed 2013-06-19 | -$377.00 derived: sum of 4 quarters · filed 2013-06-19 | |||
| 2012-01-31 | -$274.00 10-Q/A · filed 2013-03-25 | $274.00 10-Q · filed 2012-03-16 | -$716.00 derived: sum of 2 quarters · filed 2013-03-25 | -$4.08K derived: sum of 3 quarters · filed 2013-03-25 | ||||
| 2011-10-31 | -$442.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | -$3.81K derived: sum of 2 quarters · filed 2013-01-29 | -$3.44K 10-K · filed 2013-01-29 | $3.44K 10-K · filed 2012-01-30 | ||||
| 2011-07-31 | -$3.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-14 | -$3.00K 10-Q · filed 2012-09-14 | ||||||
| 2011-04-30 | $372.00 10-Q · filed 2012-06-14 | |||||||
| 2010-10-31 | -$43.68K 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |